Circulating tumor cells (CTCs) are cancer cells that circulate in the blood stream after being
naturally shed from original or metastatic tumors, and can lead to a new fatal metastasis …

Circulating tumor cells, a component of the “liquid biopsy”, hold great potential to transform
the current landscape of cancer therapy. A key challenge to unlocking the clinical utility of …

The importance of early cancer diagnosis and improved cancer therapy has been clear for
years and has initiated worldwide research towards new possibilities in the care strategy of …

Circulating tumor cells (CTCs) are rare cancer cells that are shed from primary or metastatic
tumors into the peripheral blood circulation. Phenotypic and genetic characterization of …

Circulating tumor cell (CTC)-based liquid biopsies provide unique opportunities for cancer
diagnostics, treatment selection, and response monitoring, but even with advanced …

Food safety is a major concern in the context of rising population and decreasing earth
resources. Food is often contaminated by bacteria, viruses, fungi and parasites, which …

The ability to isolate and analyze rare circulating tumor cells (CTCs) has the potential to
further our understanding of cancer metastasis and enhance the care of cancer patients. In …

Circulating tumor cells (CTCs) are shed into the bloodstream from primary and metastatic
tumor deposits. Their isolation and analysis hold great promise for the early detection of …

Since the introduction of the concept of Micro Total Analysis System or µTAS in 1990, 1 the
interest in and impact of such devices, also called lab-on-a-chip or miniaturized analysis …

Rapid point-of-care (POC) diagnostics that enable specific cellular and molecular detection
are currently being developed while some have already become clinical reality. These …